Portal de Periódicos da CAPES

Assessment of Sexual Dysfunction Using the Arizona Sexual Experiences Scale (ASEX) and Implications for the Treatment of Depression

1999; Slack Incorporated (United States); Volume: 29; Issue: 1 Linguagem: Inglês

10.3928/0048-5713-19990101-10

1938-2456

Cynthia A. McGahuey, Pedro L. Delgado, Alan J. Gelenberg,

Menopause: Health Impacts and Treatments

SEXUAL DISORDERS IN WOMENAssessment of Sexual Dysfunction Using the Arizona Sexual Experiences Scale (ASEX) and Implications for the Treatment of Depression Cynthia A McGahuey, AA, , , AA Pedro L Delgado, MD, , and , MD Alan J Gelenberg, MD, , MD Cynthia A McGahuey, AA , Pedro L Delgado, MD , and Alan J Gelenberg, MD Psychiatric Annals, 2013;29(1):39–45Published Online:January 01, 1999https://doi.org/10.3928/0048-5713-19990101-10View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Mathew RJ, Weinman M, Claghorn JL. Tricyclic side effects without tricyclics in depression. Psychopharmacol Bull. 1980;16:58-60. Google Scholar2. Casper RC, Remond DE Jr, Katz MM, et al. Somatic symptoms in primary affective disorder. Arch Gen Psychiatry. 1985;42:1098-1104. Google Scholar3. Kivela S-L, Pahkala K Clinician-related symptoms and signs of depression in aged Finns. InI J Soc Psychiatry. 1988;34:274-284. Google Scholar4. Seagraves RT. Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies. Journal of Clinical Psychiatry Monograph. 1993;11: 57-60. Google Scholar5. Monteiro WO, Noshirvani HF, Marks IM, et al. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry. 1987;151: 107-112. Google Scholar6. Piazza LA, Markowitz JC, Kocsis JH, et al. Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry. 1997;154:1757-1758. Google Scholar7. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, et al. SSRIinduced sexual dysfunction: fluoxetine, paroxetine, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23:176-194. Google Scholar8. Modell JG, Katholi CR, Modell JD, et al. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther. 1997;61:476-487. Google Scholar9. Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull. 1997;33:755-760. Google Scholar10. Balon R. Fluoxetine and sexual dysfunction. JAMA. 1995;273:1489-1490. Letter. Google Scholar11. Derogatis LR, Melisaratos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther. 1979;5:244-281. Google Scholar12. Reynolds CF, Frank E, Thase ME, et al. Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a brief sexual function questionnaire for men. Psychiatry Res. 1988;24:231-250. Google Scholar13. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for women. Arch Sex Behav. 1994;23:627-643 Google Scholar14. Anderson BL, Broffitt B. Is there a reliable and valid selfreport measure of sexual behavior? Arch Sex Behau. 1988;17:509-525. Google Scholar15. Clayton AH, Owens JE, McGarvey EL. Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire. Psychopharmacol. Bull. 1995;3:397-413. Google Scholar16. McGahuey CA, Gelenberg AJ, Laukes C, et al. The Arizona Sexual Experiences Scale (ASEX). Presented at the 38th Annual Meeting of the New Clinical Drug Evaluation Unit Program; Boca Raton, FL; June 11, 1998. Poster. Google Scholar17. Rothschild AJ. Selective serotonin reuptake inhibitorinduced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995;152:1514-1516. Google Scholar18. Shen WW, Hsu JH. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients. Int. J Psychiatry Med. 1995;25:239-248. Google Scholar19. Young AJ, Currie A, Ashton CH. Antidepressant withdrawal syndrome. Br J Psychiatry. 1997;170:288. Google Scholar20. Lejoyeux M, Ades J. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry. 1997;58Suppl 7):11-16. Google Scholar21. Gelenberg AJ. SRI withdrawal reactions, Biological Therapies in Psychiatry. 1998;21:21-22. Letter. Google Scholar22. Zajecka J, Tracy KA, Mitchell S. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry. 1997;58:1-7. Google Scholar23. Berber MJ. FINISH: remembering the discontinuation syndrome. J Clin Psychiatry. 1998;59:256. Google Scholar24. Giakas WJ, Davis JM. Intractable withdrawal from venlafaxine treated with fluoxetine. Psychiatric Annals. 1997;27:85-86, 92. Google Scholar25. McCormick S, Olin J, Brotman AW. Reversal of fluoxetineinduced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51:383-384. Google Scholar26. Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol. 1995; 18: 320-324. Google Scholar27. Reynolds RD. Sertraline-induced anorgasmia treated with intermittent nefazodone. J Clin Psychiatry. 1997;58:89. Google Scholar28. Gelenberg AJ, Laukes C, McGahuey CA, * et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. Presented at the 38th Annual Meeting of the New Clinical Drug Evaluation Unit Program; Boca Raton, FL; June 12, 1998. Poster. Google Scholar29. Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther. 1996;22:290-292. Google Scholar30. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry. 1994;55:406-413. Google Scholar31. Lane RM. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction: incidence, possible etiology and implications for management. J Psyckopharmacol. 1997;11:72-82. Google Scholar32. Jacobsen FM Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry. 1992;53:119-122. Google Scholar33. Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59:112-115. Google Scholar34. Cohen AJ, Bartlik G. Ginkgo biloba for antidepressantinduced sexual dysfunction. J Sex Marital Ther. 1993;24:139-143. Google Scholar35. Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry. 1998;53: 119-122. Google Scholar36. Bodkin JA, Lasser RA, Wines JD, et al. Combining serotonin reuptake inhibitors and bupropion in partial responderá to antidepressant monotherapy. J Clin Psychiatry. 1997;58:137-145. Google Scholar37. Nutt D. Mirtazapine: pharmacology in relation to adverse effects. Acta Psychiatr Scand. 1997;96<8uppl 3911:31-37. Google Scholar38. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997;17:10-21. Google Scholar39. Gelenberg AJ. St. John's wort: a review. Biological Therapies in Psychiatry. 1997;20:15-16. Google Scholar Previous article Next article FiguresReferencesRelatedDetails Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 8.8 MB Published online1/01/99